Google Ventures is betting more and more on life sciences startups each year, and the well-funded financier tells The Wall Street Journal that’s not going to change in the new year. In 2014, Google poured more than one-third of its $425 million venture fund into healthcare and life sciences companies, according to lead investor Bill Maris, up from just 9% in 2013. And, rolling into next year, Maris expects Google Ventures to maintain roughly the same dollar value and strategic focus.
Google Ventures, the investment arm tasked with spending the search giant’s billions on exciting new companies, released its annual report last night. Interestingly, the majority of its money did not go into the areas of consumer internet services, mobile apps, and enterprise software that Google is best known for. Instead, of the $1.6 billion it has under management, it put a whopping 35 percent of its new bets in 2014 into the category of life sciences and health, way up from less than 10 percent in the two years prior. So we hopped on the phone with Bill Maris, the managing partner who helped create Google Ventures, to get his take on why life science is such an exciting area and what lies ahead in 2015.
NOTE: TECHi Two-Takes are the stories we have chosen from the web along with a little bit of our opinion in a paragraph. Please check the original story in the Source Button below.
TECHi weighs both sides before reaching a conclusion.
TECHi’s editorial take above outlines the reasoning that supports this position.
Microsoft's Copilot AI in Windows 11 falls short of user expectations, especially when compared to the company’s high-profile advertisements. Real-world…
Apple's idea to use OLED screens for gadgets shows how keen they are to boost how things look and feel.…
The Pixel Watch 4 is a new milestone in the world of smartwatches offered by Google. It brings several firsts,…
This most recent leak of Apple has got everybody talking in the tech world. The emerging code suggests substantial updates…
